SBI Healthcare Opportunities Fund Direct Growth
Add To Comparepreviously known as SBI Pharma Dir Gr until
NAV on January 06, 2026
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
4,131 cr
Turnover Ratio
26.45%
Expense Ratio
0.91%
Exit Load
0.50%
if redeemed within
Returns
- 1M: -0.13%
- 1Y: -0.92%
- 3M: 0.52%
- 3Y: 25.95%
- 6M: -1.51%
- 5Y: 17.48%
Other plans of SBI Healthcare Opportunities